These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
843 related articles for article (PubMed ID: 32937246)
1. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Yao Y; Chen H; Yan L; Wang W; Wang D Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246 [TBL] [Abstract][Full Text] [Related]
2. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids. Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709 [TBL] [Abstract][Full Text] [Related]
3. Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Chen H; Zhang F; Li R; Liu Y; Wang X; Zhang X; Xu C; Li Y; Guo Y; Yao Q Biomed Pharmacother; 2020 Apr; 124():109829. PubMed ID: 31958765 [TBL] [Abstract][Full Text] [Related]
4. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. Fang Y; Zhang J; Zhu S; He M; Ma S; Jia Q; Sun Q; Song L; Wang Y; Duan L Pharmacol Res; 2021 Mar; 165():105439. PubMed ID: 33493658 [TBL] [Abstract][Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis. Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q Front Immunol; 2020; 11():588079. PubMed ID: 33072135 [TBL] [Abstract][Full Text] [Related]
6. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Li CN; Wang X; Lei L; Liu MZ; Li RC; Sun SJ; Liu SN; Huan Y; Zhou T; Liu Q; Cao H; Bai GL; Han YW; Shen ZF Phytother Res; 2020 May; 34(5):1166-1174. PubMed ID: 31833107 [TBL] [Abstract][Full Text] [Related]
7. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications. Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209 [TBL] [Abstract][Full Text] [Related]
8. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Wang Y; Shou JW; Li XY; Zhao ZX; Fu J; He CY; Feng R; Ma C; Wen BY; Guo F; Yang XY; Han YX; Wang LL; Tong Q; You XF; Lin Y; Kong WJ; Si SY; Jiang JD Metabolism; 2017 May; 70():72-84. PubMed ID: 28403947 [TBL] [Abstract][Full Text] [Related]
9. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228 [TBL] [Abstract][Full Text] [Related]
10. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. Wang Y; Liu H; Zheng M; Yang Y; Ren H; Kong Y; Wang S; Wang J; Jiang Y; Yang J; Shan C Front Endocrinol (Lausanne); 2021; 12():609134. PubMed ID: 34025574 [TBL] [Abstract][Full Text] [Related]
11. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites. Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238 [TBL] [Abstract][Full Text] [Related]
12. Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites. Shen HR; Xu X; Ye D; Li XL Gynecol Obstet Invest; 2021; 86(4):388-397. PubMed ID: 34515131 [TBL] [Abstract][Full Text] [Related]
13. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats. Zhao JD; Li Y; Sun M; Yu CJ; Li JY; Wang SH; Yang D; Guo CL; Du X; Zhang WJ; Cheng RD; Diao XC; Fang ZH World J Gastroenterol; 2021 Feb; 27(8):708-724. PubMed ID: 33716449 [TBL] [Abstract][Full Text] [Related]
14. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway. Wang X; Liang F; Dai Z; Feng X; Qiu F J Ethnopharmacol; 2024 Jan; 318(Pt B):117050. PubMed ID: 37595814 [TBL] [Abstract][Full Text] [Related]
15. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224 [TBL] [Abstract][Full Text] [Related]
16. The Effects of Berberine on the Gut Microbiota in Apc Wang H; Guan L; Li J; Lai M; Wen X Molecules; 2018 Sep; 23(9):. PubMed ID: 30205580 [No Abstract] [Full Text] [Related]
17. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin. Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839 [TBL] [Abstract][Full Text] [Related]
18. Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM/DSS-induced colitis-associated colorectal cancer. Wang M; Ma Y; Yu G; Zeng B; Yang W; Huang C; Dong Y; Tang B; Wu Z Biomed Pharmacother; 2024 Oct; 179():117292. PubMed ID: 39151314 [TBL] [Abstract][Full Text] [Related]
19. Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites. Chen Y; Hao Z; Zhao H; Duan X; Jia D; Li K; Yang Y; Cui H; Gao M; Zhao D J Sci Food Agric; 2023 Feb; 103(3):1464-1473. PubMed ID: 36168925 [TBL] [Abstract][Full Text] [Related]
20. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Yue SJ; Liu J; Wang AT; Meng XT; Yang ZR; Peng C; Guan HS; Wang CY; Yan D Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E73-E85. PubMed ID: 30422704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]